Skip to content
WomanCart IPO booked 7 times on Day 2, retail portion bought 12 times

WomanCart IPO booked 7 times on Day 2, retail portion bought 12 times

WomanCart#39;s Rs 9.56 crore IPO is entirely a fresh issue of 11,12,000 shares and there is no offer-for-sale component.

Read More

​ WomanCart#39;s Rs 9.56 crore IPO is entirely a fresh issue of 11,12,000 shares and there is no offer-for-sale component. WomanCart#39;s Rs 9.56 crore IPO is entirely a fresh issue of 11,12,000 shares and there is no offer-for-sale component.  Moneycontrol Latest News Read More  

WomanCart#39;s Rs 9.56 crore IPO is entirely a fresh issue of 11,12,000 shares and there is no offer-for-sale component.

Top Nifty gainers and losers at mid-day: BPCL, HDFC Life rise, UPL, Maruti down

Top Nifty gainers and losers at mid-day: BPCL, HDFC Life rise, UPL, Maruti down

The market was trading higher on positive global cues and broad-based buying. About 2,091 shares advanced, 1,027 declined, and 131 were unchanged

Read More

​ The market was trading higher on positive global cues and broad-based buying. About 2,091 shares advanced, 1,027 declined, and 131 were unchanged The market was trading higher on positive global cues and broad-based buying. About 2,091 shares advanced, 1,027 declined, and 131 were unchanged  Moneycontrol Latest News Read More  

The market was trading higher on positive global cues and broad-based buying. About 2,091 shares advanced, 1,027 declined, and 131 were unchanged

Glenmark gets USFDA nod to market generic version of Otezla tablets

Glenmark gets USFDA nod to market generic version of Otezla tablets

The company has received final approval from the US Food Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.

Read More

​ The company has received final approval from the US Food Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement. The company has received final approval from the US Food Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.  Moneycontrol Latest News Read More  

The company has received final approval from the US Food Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.

India to see “healthy growth” in steel demand at 8.6% in 2023: worldsteel

India to see “healthy growth” in steel demand at 8.6% in 2023: worldsteel

It forecasts that global steel demand will grow 1.8 per cent in 2023 and reach 1,814.5 MT after having contracted by 3.3 per cent in 2022. In 2024, the demand will see an increase of 1.9 per cent to 1,849.1 MT, the World Steel Association (worldsteel) said.

Read More

​ It forecasts that global steel demand will grow 1.8 per cent in 2023 and reach 1,814.5 MT after having contracted by 3.3 per cent in 2022. In 2024, the demand will see an increase of 1.9 per cent to 1,849.1 MT, the World Steel Association (worldsteel) said. It forecasts that global steel demand will grow 1.8 per cent in 2023 and reach 1,814.5 MT after having contracted by 3.3 per cent in 2022. In 2024, the demand will see an increase of 1.9 per cent to 1,849.1 MT, the World Steel Association (worldsteel) said.  Moneycontrol Latest News Read More  

It forecasts that global steel demand will grow 1.8 per cent in 2023 and reach 1,814.5 MT after having contracted by 3.3 per cent in 2022. In 2024, the demand will see an increase of 1.9 per cent to 1,849.1 MT, the World Steel Association (worldsteel) said.

KIOCL shares hit 20% upper circuit for second straight session, at fresh 52-wk high

KIOCL shares hit 20% upper circuit for second straight session, at fresh 52-wk high

In the last five days, KIOCL shares have rallied more than 44 percent. In the past year, the stock has demonstrated consistent growth with gains of around 160 percent

Read More

​ In the last five days, KIOCL shares have rallied more than 44 percent. In the past year, the stock has demonstrated consistent growth with gains of around 160 percent In the last five days, KIOCL shares have rallied more than 44 percent. In the past year, the stock has demonstrated consistent growth with gains of around 160 percent  Moneycontrol Latest News Read More  

In the last five days, KIOCL shares have rallied more than 44 percent. In the past year, the stock has demonstrated consistent growth with gains of around 160 percent

J Kumar Infra bags Rs 509 crore project; stock hits 52-week high

J Kumar Infra bags Rs 509 crore project; stock hits 52-week high

Compared to Nifty 50#39;s one-year run of 14.8 percent, shares of the firm jumped 82.6 percent during the same time period. The counter sees high volatility, as indicated by the one-year beta of 1.17

Read More

​ Compared to Nifty 50#39;s one-year run of 14.8 percent, shares of the firm jumped 82.6 percent during the same time period. The counter sees high volatility, as indicated by the one-year beta of 1.17 Compared to Nifty 50#39;s one-year run of 14.8 percent, shares of the firm jumped 82.6 percent during the same time period. The counter sees high volatility, as indicated by the one-year beta of 1.17  Moneycontrol Latest News Read More  

Compared to Nifty 50#39;s one-year run of 14.8 percent, shares of the firm jumped 82.6 percent during the same time period. The counter sees high volatility, as indicated by the one-year beta of 1.17

Rolls-Royce to cut up to 2,500 roles in latest efficiency drive

Rolls-Royce to cut up to 2,500 roles in latest efficiency drive

Over the last decade, Rolls-Royce, whose engines and systems are used on the Airbus A350 and Boeing 787 as well as ships, submarines and in power generation, has been through several restructurings, cutting over 13,000 jobs.

Read More

​ Over the last decade, Rolls-Royce, whose engines and systems are used on the Airbus A350 and Boeing 787 as well as ships, submarines and in power generation, has been through several restructurings, cutting over 13,000 jobs. Over the last decade, Rolls-Royce, whose engines and systems are used on the Airbus A350 and Boeing 787 as well as ships, submarines and in power generation, has been through several restructurings, cutting over 13,000 jobs.  Moneycontrol Latest News Read More  

Over the last decade, Rolls-Royce, whose engines and systems are used on the Airbus A350 and Boeing 787 as well as ships, submarines and in power generation, has been through several restructurings, cutting over 13,000 jobs.

Ajmera Realty to redevelop housing society in Versova, Mumbai, targets sales of Rs 360 crore

Ajmera Realty to redevelop housing society in Versova, Mumbai, targets sales of Rs 360 crore

The project is expected to comprise 3 BHK residential apartments with an estimated carpet area of around 90,700 sq ft

Read More

​ The project is expected to comprise 3 BHK residential apartments with an estimated carpet area of around 90,700 sq ft The project is expected to comprise 3 BHK residential apartments with an estimated carpet area of around 90,700 sq ft  Moneycontrol Latest News Read More  

The project is expected to comprise 3 BHK residential apartments with an estimated carpet area of around 90,700 sq ft

Baidu says its AI as good as ChatGPT’s in bold claim for China

Baidu says its AI as good as ChatGPT’s in bold claim for China

The billionaire took the stage in Beijing Tuesday to run Ernie 4.0 through a QA designed to showcase its ability to provide answers and solve complicated puzzles on the fly.

Read More

​ The billionaire took the stage in Beijing Tuesday to run Ernie 4.0 through a QA designed to showcase its ability to provide answers and solve complicated puzzles on the fly. The billionaire took the stage in Beijing Tuesday to run Ernie 4.0 through a QA designed to showcase its ability to provide answers and solve complicated puzzles on the fly.  Moneycontrol Latest News Read More  

The billionaire took the stage in Beijing Tuesday to run Ernie 4.0 through a QA designed to showcase its ability to provide answers and solve complicated puzzles on the fly.

Buy Federal Bank; target of Rs 175: ICICI Securities

Buy Federal Bank; target of Rs 175: ICICI Securities

ICICI Securities is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 175 in its research report dated October 17, 2023.

Read More

​ ICICI Securities is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 175 in its research report dated October 17, 2023. ICICI Securities is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 175 in its research report dated October 17, 2023.  Moneycontrol Latest News Read More  

ICICI Securities is bullish on Federal Bank recommended buy rating on the stock with a target price of Rs 175 in its research report dated October 17, 2023.

en_USEnglish